Business Description
![Hepion Pharmaceuticals Inc Hepion Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000AGTD.png?14)
Hepion Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US21234W2026
Description
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 74.89 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.02 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 33.3 | |||||
3-Year EPS without NRI Growth Rate | 35.3 | |||||
3-Year FCF Growth Rate | 32.6 | |||||
3-Year Book Growth Rate | -63.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.4 | |||||
9-Day RSI | 38.28 | |||||
14-Day RSI | 38.99 | |||||
6-1 Month Momentum % | -57.64 | |||||
12-1 Month Momentum % | -88.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.99 | |||||
Quick Ratio | 5.99 | |||||
Cash Ratio | 5.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -44.4 | |||||
Shareholder Yield % | -1.75 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -203.85 | |||||
ROA % | -132.75 | |||||
ROIC % | -969.7 | |||||
ROC (Joel Greenblatt) % | -25118.25 | |||||
ROCE % | -184.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.94 | |||||
Price-to-Tangible-Book | 0.94 | |||||
EV-to-EBIT | 0.14 | |||||
EV-to-EBITDA | 0.14 | |||||
EV-to-FCF | 0.16 | |||||
Price-to-Net-Current-Asset-Value | 1.04 | |||||
Price-to-Net-Cash | 1.18 | |||||
Earnings Yield (Greenblatt) % | 714.29 | |||||
FCF Yield % | -663.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HEPA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hepion Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -9.4 | ||
Beta | 1.75 | ||
Volatility % | 92.37 | ||
14-Day RSI | 38.99 | ||
14-Day ATR ($) | 0.113433 | ||
20-Day SMA ($) | 1.077955 | ||
12-1 Month Momentum % | -88.85 | ||
52-Week Range ($) | 0.9 - 11.07 | ||
Shares Outstanding (Mil) | 5.47 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hepion Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hepion Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Hepion Pharmaceuticals Inc Frequently Asked Questions
What is Hepion Pharmaceuticals Inc(HEPA)'s stock price today?
The current price of HEPA is $1.00. The 52 week high of HEPA is $11.07 and 52 week low is $0.90.
When is next earnings date of Hepion Pharmaceuticals Inc(HEPA)?
The next earnings date of Hepion Pharmaceuticals Inc(HEPA) is 2024-08-14 Est..
Does Hepion Pharmaceuticals Inc(HEPA) pay dividends? If so, how much?
Hepion Pharmaceuticals Inc(HEPA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |